Tim Russert to speak at NACDS Foundation dinner
ALEXANDRIA, Va. The National Association of Chain Drug Stores Foundation announced Thursday that journalist Tim Russert will speak at the 9th Annual NACDS Foundation Dinner.
Russert currently works as managing editor and moderator of “Meet the Press,” as well as being a political analyst for “NBC Nightly News” and the “Today Program,” He is also a contributing anchor for MSNBC. His professionalism has earned him the role of host to his own show, “The Tim Russert Show,” a weekly interview program on MSNBC. Russert also serves as senior vice president and Washington bureau chief of NBC News.
NACDS Foundation president Phil Schneider said Russert was the perfect person to be the foundation’s guest speaker because of his ability to give back to the community, particularly through volunteer leadership positions with the Greater Washington Boys and Girls Clubs and the America’s Promise programs.
“Tim Russert is a man who exemplifies commitment. He demonstrates commitment to his industry, his family and his community,” Schneider said.
The NACDS Foundation’s mission is to enhance support of pharmacy education, student scholarships, research and training that advance community pharmacy’s public service and charitable organizations. In the past, the annual dinner attendees have graciously generated significant financial support for quality programs and research to further advance community pharmacy.
N.J. Rep. criticizes FDA over weaker antidepressant warnings for children
WASHINGTON Rep. Mike Ferguson, R-N.J., is criticizing the Food and Drug Administration, for its revised antidepressant medication guides because the warnings for children take the medications have been weakened compared to the old guide.
Ferguson said the guides include more generalized information regarding the risks for children, teenagers and young adults taking antidepressants. He also stated that the new guides use a generic warning that combines all three age groups into one category and abbreviates safety information.
In October 2003, the FDA issued an advisory warning of the increased risk of suicide in pediatric patients taking selective serotonin reuptake inhibitors for depression. After reviewing more data from pediatric studies, the agency told antidepressant manufacturers to revise their product labeling to include the risk of suicide in children and adolescents.
Herbert Luther appointed Perrigo’s VP of global regulatory affairs
ALLEGAN, Mich. Perrigo has announced that Herbert Luther will become the company’s vice president, global regulatory affairs.
In this role, Luther will be responsible for developing and executing regulatory-submission strategies, ensuring best practices, and implementing technologies to enhance efficiency.
Luther has over 20 years experience in the development of regulatory and clinical strategies. Before joining Perrigo, he worked at KV Pharmaceuticals, where he was vice president of regulatory/clinical affairs. Before that, he served as director of regulatory affairs at Barr Laboratories.